Bv8-prokineticins and their receptors: Modulators of pain

Current Pharmaceutical Biotechnology

Volumn 12, Issue 10, 2011, Pages 1720-1727

  Negri, Lucia ^a   Lattanzi, Roberta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bv8 PK2; Inflammatory pain; Nociception; Prokineticin receptors; Prokineticins

Indexed keywords

ANALGESIC AGENT; CALCITONIN GENE RELATED PEPTIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; ICOSANOID; NEUROPEPTIDE Y RECEPTOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROKINETICIN 2; PROKINETICIN RECEPTOR 1; PROKINETICIN RECEPTOR 2; PROKINETICIN RECEPTOR ANTAGONIST; PROTEIN BV8; PROTEIN KINASE C; SUBSTANCE P; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ALLODYNIA; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; CIRCADIAN RHYTHM; CYTOKINE RELEASE; HEMATOPOIESIS; HUMAN; HYPERALGESIA; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY PAIN; INTESTINE MOTILITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUTROPHIL; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; PAIN THRESHOLD; SENSITIZATION; SENSORY NERVE; SKIN; SPINAL CORD; STIMULUS RESPONSE; UPREGULATION;

AMPHIBIA; ANURA; MAMMALIA; RODENTIA;

EID: 80053551883     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798357410     Document Type: Article

References (60)

1. Negri, L.; Lattanzi, R.; Giannini, E.; Melchiorri, P. Bv8/Prokineticin proteins and their receptors. Life Sci., 2007, 81, 1103-1116.
2. Monnier, J.; Samnson, M. Cytokine properties of prokineticins. FEBS J., 2008, 275, 4014-4021.
3. Lin, D.C.H.; Bullock, C.M.; Ehlert, F.J.; Chen, J.L.; Thian, H.; Zhou, Q.Y. Identification and molecular characterization of two closely related G-protein coupled receptors activated by prokineticins/ EG-VEGF. J. Biol. Chem., 2002, 277, 19276-19280.
4. Masuda, Y.; Takatsu, Y.; Terao, Y.; Kumano, S.; Ishibashi, Y.; Suenaga, M.; Abe, M.; Fukusumi, S.; Watanabe, T.; Shintani, Y.; Yamada, T.; Hinuma, S.; Inatomi, N.; Ohtaki, T.; Onda, H.; Fujino, M. Isolation and identification of EG-VEGF/ prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem. Biophys. Res. Commun., 2002, 293, 396-402.
5. Soga, T.; Matsumoto, S.I.; Oda, T.; Saito, T.; Hiyama, H.; Takasaki, J.; Kamohara, M.; Ohishi, T.; Matsushime, H.; Furuichi, K. Molecular cloning and characterization of prokineticin receptors Biochim. Biophis. Acta, 2002, 1579, 173-179.
6. Shojaei, F.; Wu, X.; Zhong, C.; Yu, L.; Liang, X.H.; Yao, J.; Blanchard, D.; Bais, C.; Peale, F.V.; Van Bruggen, N.; Ho, C.; Ross, J.; Tan, M.; Carano, R.A.; Meng, Y.G.; Ferrara, N. Bv8 regulates myeloid-cell-dependent tumor angiogenesis. Nature, 2007, 450, 825-831.
7. Chen, J.; Kuei, C.; Sutton, S.; Wilson, S.; Yu, J.; Kamme, F.; Mazur, C., Lovenberg, T.; Liu, C. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1. Mol. Pharmacol., 2005, 67, 2070-2076.
8. Giannini, E.; Lattanzi, R.; Nicotra, A.; Campese, A.F.; Grazioli, P.; Screpanti, I.; Balboni, G.; Salvadori, S.; Sacerdote, P.; Negri, L. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc. Natl. Acad. Sci. USA, 2009, 106 (34), 14646-14651.
9. Martucci, C.; Franchi, S.; Giannini, E.; Tian, H.; Melchiorri, P.; Negri, L.; Sacerdote, P. Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br. J. Pharmacol., 2006, 147, 225-234.
10. Koyama, Y.; Kiyo-oka, M.; Osakada, M.; Horiguchi, N.; Shintani, N.; Ago, Y.; Kakuda, M.; Babab, A.; Matsuda, T. Expression of prokineticin receptors in mouse cultured astrocytes and involvement in cell proliferation. Brain Res., 2006, 1112, 65-69.
11. Cheng, M.Y.; Leslie, F.M.; Zhou, Q.Y. Expression of prokineticins and their receptors in the adult mouse brain. J. Comp. Neurol., 2006, 498, 796-809.
12. Negri, L.; Lattanzi, R.; Giannini, E.; De Felice, M.; Colucci, A.; Melchiorri, P. Bv8, the amphibian homologue of the mammalian prokineticins, modulates ingestive behaviour in rats. Br. J. Pharmacol., 2004, 142, 141-151.
13. Cheng, M.J.; Bullock C.M.; Li, C., Lee A.G., Bermak, J.C.; Belluzzi, J.; Weaver, D.R.; Leslie, F.M.; Zhou, Q.Y. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature, 2002, 417, 405-410.
14. Negri, L.; Lattanzi, R.; Giannini, E.; Colucci, M.; Margheriti, F.; Melchiorri, P.; Vellani, V.; Tian, H.; De Felice, M.; Porreca, F. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J. Neurosci. 2006, 26, 6716-6727.
15. Negri, L.; Lattanzi, R.; Giannini, E; Melchiorri, P. Modulators of Pain: Bv8 and Prokineticins. Curr. Neuropharmacol., 2006, 4, 207-215.
16. Zhang, C.; Truong, K.K.; Zhou Q.Y. Efferent projections of prokineticin 2 expressing neurons in the mouse suprachiasmatic nucleus. PLOS One, 2009, 4, 1-12.
17. Puverel, S.; Nakatani, H.; Parras, C.; Soussi-Yanicostas, N. Prokineticin receptor 2 expression identifies migrating neuroblasts and their subventricular zone transient-amplif progenitors in adult mice. J. Comp. Neurol., 2009, 512 (2), 232-242.
18. Ng, K.L.; Li J.D.; Cheng, M.Y.; Leslie, F.M.; Lee, A.G.; Zhou, Q.Y. Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science, 2005, 308, 1923-1927.
19. Zhang, C.; Ng, K.L.; Li, J.; He, F.; Anderson, D.J.; Sun, Y.E.; Zhou Q.Y. Prokineticin 2 is atarget gene of proneural basic helixloop- helix factors for olfactory bulb neurogenesis. J. Biol. Chem., 2007, 282 (10), 6917-6921.
20. Prosser, H.M.; Bradley, A.; Caldwell, M.A. Olfactory bulb hypoplasia in Prokr2 null mice stems from defective neuronal progenitor migration and differentiation. Eur. J. Neurosci., 2007, 26, 3339-3344.
21. Matsumoto, S.; Yamazaki, C.; Masumoto, K.H.; Nagano, M.; Naito, M.; Soga, T.; Hiyama, H.; Matsumoto, M.; Takasaki, J.; Kamohara, M.; Matsuo, A.; Ishii, H.; Kobori, M.; Katoh, M.; Matsushime, H.; Furuichi, K.; Shigeyoshi, Y. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc. Natl. Acad. Sci. USA, 2006, 103, 4140-4145.
22. Pitteloud, N.; Zhang, C.; Pignatelli, D.; Li, J.D.; Raivio, T.; Cole, L.W.; Plummer, L.; Jacobson Dickman, E.E.; Mellon, P.L.; Zhou, Q.Y.; Crowley Jr., W.F. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. USA, 2007, 104, 17447-17452
23. De Novellis, V.; Negri, L.; Lattanzi, R.; Francesca Rossi, F.; Palazzo, E.; Marabese, I.; Giannini, E.; Vita, D.; Melchiorri, P.; Maione S. The prokineticin receptor agonist Bv8 increases GABA release in the periaqueductal grey and modifies RVM cell activities and thermoceptive reflexes in the rat. Eur. J. Neurosci., 2007, 26, 3068-3078.
24. Lattanzi, R.; Giannini, E.; Melchiorri, P., Negri, L. Pharmacology of Bv8: a new peptide from amphibian skin. Br. J. Pharmacol., 2001, 133, 45P.
25. Hoffmann, P.; Feige, J.J.; Alfaidy, N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/ prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology, 2006, 147 (4), 1675-1684
26. Ferrara, N.; LeCouter, J.; Lin, R.; Peale, F. EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors. Biochim. Biophisyca Acta, 2004, 1654, 69-78.
27. Fraser, H.M.; Bell, J.; Wilson, H.; Taylor, P.D.; Morgan, K.; Anderson, R.A.; Duncan, W.C. Localization and quantification of cyclic changes in the expression of endocrine gland derived vascular endothelial growth factor in the human corpus luteum. J. Clin.l Endocrinol. Metabol., 2005, 90, 427-434.
28. LeCouter, J.; Kowalski, J.; Foster, J.; Hass, P.; Zhang, Z.; Dillard- Telm, L.; Frantz, G.; Rangell, L.; Deguzman, L.; Keller, G.; Peale, F.; Gurney, A., Hillan, KJ.; Ferrara, N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature, 2001, 412, 876-884.
29. LeCouter, J.; Ferrara, N. EG-VEGF and Bv8: a novel family of tissue-selective mediators of angiogenesis, endothelial phenotype and function. Trends Cardiovasc. Med., 2003, 13, 276-282.
30. Guilini, C.; Urayama, K.; Turkeri, G.; Dedeoglu, D.B.; Kurose, H.; Messaddeq, N.; Nebigil, C. G. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. Am. J. Physiol. Heart. Circ. Physiol., 2010, 298, H844-H852.
31. Kisliouk, T.; Levy, N.; Hurwitz, A.; Meidan, R. Presence and regulation of endocrine gland-derived vascular endothelial growth factor/ prokineticin 1 and its receptors in ovarian cells. J. Clin. Endocrinol. Metabol., 2003, 88, 3700-3707.
32. Kisliouk, T.; Podlovni, H.; Spanel-Borowski, K.; Ovadia, O.; Zhou, Q.Y.; Meidan, R. Prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) in the bovine ovary: expression and role as mitogens and survival factors for corpus luteum-derived endothelial cells. Endocrinology, 2005, 146, 3950-3958.
33. Kisliouk, T.; Podlovni, H.; Meidan, R. Unique expression and regulatory mechanisms of EG-VEGF/prokineticins-1 and its receptors in corpus luteum Anna. Anatomy, 2005, 187, 529-537.
34. LeCouter, J.; Lin, R.; Ferrara, N. Endocrine gland derived EGVEGF and the emerging hypothesis of organ-specific regulation of angiogenesis. Nat. Med., 2002, 8, 913-917.
35. Keramidas, M.; Faudot, C.; Cibiel, A.; Feige, J.J.; Thomas, M. Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells J. Endocrinol., 2008, 196, 473-482.
36. Maldonado-Pérez, D.; Brown, P.; Morgan, K.; Millar, R.P.; Thompson, E.A.; Jabbour, H.N. Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway. Biochim. Biophys. Acta, 2009, 1793(7), 1315-1324.
37. LeCouter, J.; Lin, R.; Tejada, M.; Frantz, G.; Peale, F.; Hillan, K.J.; Ferrara, N. The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc. Natal. Acad. Sci. USA, 2003, 100, 2685-2690.
38. Samson, M.; Peale, F.V. Jr.; Frantz, G.; Rioux-Leclercq, N.; Rajpert- De Meyts, E. Ferrara, N. Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J. Clin. Endocrinol. Metabol., 2004, 89, 4078-4088.
39. Wechselberger, C.; Puglisi, R.; Engel, E.; Lepperdinger, G.; Boitani, C.; Kreil, G. The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes. FEBS Lett.1999, 462, 177-181
40. Urayama, K.; Guilini, C.; Messaddeq, N.; Hu, K.; Steenman, M.; Kurose, H.; Ert, G.; Nebigil, C.G. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis. FASEB J., 2007, 21, 2980-2993.
41. Urayama, K.; Dedeoglu, D.B.; Guilini, C.; Frantz, S.; Ertl, G.; Messaddeq, N.; Nebigil, C.G. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary leakage. Cardiovasc. Res., 2009, 81, 28-37.
42. Ngan, E.S.; Lee, K.Y.; Sit, F.Y.; Poon, H.C.; Chan, J.K.; Sham, M.H.; Lui, V.C.; Tam, P.K. Prokineticin-1 modulates proliferation and differentiation of enteric neural crest cells. Biochim. Biophisyca Acta, 2007, 1773, 536-545.
43. Ngan, E.S.; Shum, C.K.; Poon, H.C.; Sham, M.H.; Garcia-Barcelo, M.M.; Lui, V.C.; Tam, P.K. Prokineticin-1 (ProK-1) works coordinately with glial cell line-derived neurotrophic factor (GDNF) to mediate proliferation and differentiation of enteric neural crest cell. Biochim. Biophysica Acta: Mol. Cell Res., 2008, 1783, 467-478.
44. Goi, T.; Fujioka, M.; Satoh, Y.; Tabata, S.; Koneri, K.; Nagano, H.; Hirono, Y.; Katayama, K.; Hirose, K.; Yamaguchi, A. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res., 2004, 64, 1906-1910.
45. Pasquali, D.; Rossi, V.; Staibano, S.; De Rosa, G.; Chieffi, P.; Prezioso, D.; Mirone, V.; Mascolo, M.; Tramontano, D.; Bellastella, A.; Sinisi, A.A. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EGVEGF/ prokineticin 1 with malignancy. Endocrinology, 2006, 147, 4245-4251.
46. Ngan, E.S.; Sit, F.Y.; Lee, K.L.; Miao, X.; Yuan, Z.; Wang, W.; Nicholls, J.M.; Wong, K.K.; Garcia-Barcelo, M.; Lui, V.C.; Tam, P.K. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression. Clin. Cancer Res., 2007, 13, 868-875.
47. LeCouter, J.; Zlot, C.; Tejada, M.; Peale, F.; Ferrara, N. Bv8 and endocrine gland derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc. Natl. Acad. Sci. USA, 2004, 101, 16813-16818.
48. Dorsh, M.; Qui, Y.; Soler, D; Frank, N.; Duong, T.; Goodearl, A.; O'Neil, S.; Lora, J.; Fraser, C. PK1/EG-VEGF induces monocyte differentiation and activation. J. Leukocyte Biol., 2005, 78, 426-434.
49. Kisliouk, T.; Friedman, A.; Klipper, E.; Zhou, Q.Y.; Schams, D.; Alfaidy, N.; Meidan, R. Expression pattern of prokineticin 1 and its receptors in bovine ovaries during the estrous cycle: involvement in corpus luteum regression and follicular atresia. Biol. Reproduc., 2007, 76, 749-758.
50. Franchi, S.; Giannini, E.; Lattuada, D.; Lattanzi, R.; Tian, H.; Melchiorri, P.; Negri, L.; Panerai, A.E.; Sacerdote, P. The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1. BMC I., 2008, 9, 60.
51. Zhong, C.; Qu, X.; Tan, M.; Meng, Y.C.; Ferrara, N. Characterization and regulation of Bv8 in human blood cells. Clin. Cancer Res., 2009, 15, 2875.
52. Shojaei, F.; Wu, X; Qu, X.; Kowanetz, M.; Yu, L.; Tan, M.; Meng, G.; Ferrara, G. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc. Natl. Acad. Sci. USA, 2009,106 (16), 6742-6747.
53. Shojae, F.; Ferrara, N. Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells. Cancer Res., 2008, 68 (14), 5501-5504.
54. Negri, L.; Lattanzi, R.; Giannini, E.; Metere, A.; Colucci, M.; Barra, D.; Kreil, G.; Melchiorri, P. Nociceptive sensitization by the secretory protein Bv8. Br. J. Pharmacol., 2002, 137, 1147-1154.
55. Vellani, V.; Colucci, M.; Lattanzi, R.; Giannini, E.; Negri, L;, Melchiorri, P.; McNaughton, P.A. Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8. J. Neurosci., 2006, 26, 5109-5116.
56. Tominaga, M.; Tominaga, T. Structure and function of TRPV1. Pflugers. Arch., 2005, 451, 143-150.
57. Moriyama, T. Higashi, T.; Togashi, K.; Iida, T.; Segi, E.;, Sugimoto, Y; Tominaga T Narumiya, S.; Tominaga, M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain, 2005, 1, 3.
58. Planells-Cases, R.; Garcia-Sanz, N.; Morenilla-Palao, C; Ferrer- Montiel, A. Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia. Pflugers Arch., 2005, 451, 151-159.
59. Chopra, B.; Giblett, S.; Little, J.G.; Donaldson, L.F.; Tate, S.; Evans, R.J.; Grubb, B.D. Cyclooxygenase-1 is a marker for a subpopulation of putative nociceptive neurons in rat dorsal root ganglia. Eur. j. Neurosci., 2000, 12, 911-920.
60. Balboni, G.; Lazzari, I.; Trapella, C.; Negri, L.; Lattanzi, R.; Giannini, E.; Nicotra, A.; Melchiorri, P.; Visentin, S.; DeNuccio, C.; Salvadori, S. Triazine compounds as antagonists at Bv8- prokineticin receptors. J. Med. Chem., 2008, 51, 7635-7639.